Biodegradable Implants Containing Gentamicin: Drug Release and Pharmacokinetics

Abstract

To estimate the releasing and pharmacokinetic features of antibiotics used in implantable delivery devices the implants based on stable carrier i.e. polymethylmethacrylate (Septopal) and biodegradable carriers i.e. copolymers of 2-hydroxyethylmethacry-late, N-vinylpyrrolidone and allylic alcohol, mono-carboxylcellulose, collagen, alginic acid and its mixed sodium-calcium salt were studied comparatively. It was shown in_vitro that the implants on the base of polymethylmethacrylate, collagen (especially cross-linked one), alginic acid and monocarboxylcel-lulose had the most pronounced prolongation effect. For the samples using alginic acid and monocarboxyl-cellulose the antibiotic release rate was closely connected with eluent content. The changes of gentamicin levels in the implantation zones were of three-phase character. The drug concentration reached its maximum in phase I, was practically constant in phase II and slowly lowered in phase III. The comparison of the concentration levels and areas under cocentration-time curves showed that the sustained release and pharmacokinetic characteristics of the implants based on cross-linked collagen, alginic acid and monocarbo-xylcellulose were similar to those of polymethylmethacrylate.     

Biodegradable Implants Containing Gentamicin: Drug Release and Pharmacokinetics

To estimate the releasing and pharmacokinetic features of antibiotics used in implantable delivery devices the implants based on stable carrier i.e. polymethylmethacrylate (Septopal) and biodegradable carriers i.e. copolymers of 2-hydroxyethylmethacry-late, N-vinylpyrrolidone and allylic alcohol, mono-carboxylcellulose, collagen, alginic acid and its mixed sodium-calcium salt were studied comparatively. It was shown in_vitro that the implants on the base of polymethylmethacrylate, collagen (especially cross-linked one), alginic acid and monocarboxylcel-lulose had the most pronounced prolongation effect. For the samples using alginic acid and monocarboxyl-cellulose the antibiotic release rate was closely connected with eluent content. The changes of gentamicin levels in the implantation zones were of three-phase character. The drug concentration reached its maximum in phase I, was practically constant in phase II and slowly lowered in phase III. The comparison of the concentration levels and areas under cocentration-time curves showed that the sustained release and pharmacokinetic characteristics of the implants based on cross-linked collagen, alginic acid and monocarbo-xylcellulose were similar to those of polymethylmethacrylate.     

Release Kinetics of Tobramycin Sulfate from Polymethylmethacrylate Implants

Abstract

The effects of various formulation factors on the in vitro release characteristics of spherical polymethylmethacrylate implants were studied. Physical and mathematical models were proposed to describe observed in vitro release profiles. The in vitro release data could be described by a biexponential equation of the type: fraction of tobramycin remaining in the implant at time t = Ae^?αt + Be^?βt, where α and β represent the rate constants for the initial rapid and subsequent slow phases of release. The influence of drug loading, volume of dissolution medium, implant size, type of commercial cement and the incorporation of water soluble additives on the release profiles as well as the α and β rate constants is described     

Influence of Drug Loading and Gel Structure on in-Vitro Release Kinetics from Photopolymerized Gels

Precious work has shown that stabls and homogenous poly HEMA gels can be prepared using a visible light sensitive initiator system. Gels were prepared from solutions of water and poly-2-hydroxyethyl methacrylate monomer. At concentrations of water greater than 10% v/v, translucent gel resulted. However, polymerization solvents such as glycerol and tertiary butyl alcohol (T.B.T.A) gave transparent, flexible gels over a wider range of concentrations. Subsequent work showed that changes in polymerization solvent and monomer concentration brought about changes in the mechanical and structural properties of the gels.

In this work, the effects of drug loading and polymerization solvents on in vitro drug release rate from the photopolymerized polyHEMA gels were studied. Polymerization solvents used included glycerol and tertiary butyl alcohol. Results indicated that the release rate in vitro was a diffusion-controlled process except at high drug concentrations in poly HEMA - T.B.T.A. gels when a departure from root-time kinetics occurred. Poly HEMA T.B.T.A. gels presented greater hindeirance to the mobility of the drug than polyHEMA - glycerol gels. Higuch's model for release from incoluble homogenous matrices containing dispersed solute was found to be inappropriate for the analysis of the release of the drug from the gels. A simple equation based on the modelling of desorption in diffusion was found more appropriate. Estimates of drug release rates in vitro may be made from measurements of the physical crosslinking density of the polymer (if matrix-diffusion controlled release is operative). Quantitative drug loading was achieved in the gels as evidenced from variation in crosslinking density and in vitro release rate with drug loading.     

Influence of Drug Loading and Gel Structure on in-Vitro Release Kinetics from Photopolymerized Gels

Abstract

Precious work has shown that stabls and homogenous poly HEMA gels can be prepared using a visible light sensitive initiator system. Gels were prepared from solutions of water and poly-2-hydroxyethyl methacrylate monomer. At concentrations of water greater than 10% v/v, translucent gel resulted. However, polymerization solvents such as glycerol and tertiary butyl alcohol (T.B.T.A) gave transparent, flexible gels over a wider range of concentrations. Subsequent work showed that changes in polymerization solvent and monomer concentration brought about changes in the mechanical and structural properties of the gels.

In this work, the effects of drug loading and polymerization solvents on in vitro drug release rate from the photopolymerized polyHEMA gels were studied. Polymerization solvents used included glycerol and tertiary butyl alcohol. Results indicated that the release rate in vitro was a diffusion-controlled process except at high drug concentrations in poly HEMA - T.B.T.A. gels when a departure from root-time kinetics occurred. Poly HEMA T.B.T.A. gels presented greater hindeirance to the mobility of the drug than polyHEMA - glycerol gels. Higuch's model for release from incoluble homogenous matrices containing dispersed solute was found to be inappropriate for the analysis of the release of the drug from the gels. A simple equation based on the modelling of desorption in diffusion was found more appropriate. Estimates of drug release rates in vitro may be made from measurements of the physical crosslinking density of the polymer (if matrix-diffusion controlled release is operative). Quantitative drug loading was achieved in the gels as evidenced from variation in crosslinking density and in vitro release rate with drug loading.     

The Influence of Drug Solubility and Particle Size on the Pellet Formulation in a Rotoprocessor

ABSTRACT

Pellets containing drugs of different properties were prepared in a Rotoprocessor in order to study changes in the formulation process and resulting pellet characteristics. Diltiazem hydrochloride, diclofenac sodium, and theophylline were chosen as model drugs. Pellet size distribution, sphericity, density, hardness, friability, and repose angle were determined using standard methods. The amount of water as a wetting agent necessary for successful pellet formulation was observed for each sample and changed depending on drug solubility, concentration, and particle size. The pelletization of freely soluble diltiazem hydrochloride required 24.8–23.1% of the wetting agent and its amount decreased as the drug concentration increased. The demand for water in the formulation of theophylline pellets was 31.0–34.4% and it increased with increasing drug concentration. The pellet samples containing both drugs were easy to prepare. However, the cohesion of micronized diclofenac sodium particles negatively influenced both the pellet size distribution and the formulation process itself. When the drug concentration exceeded 40%, it was not possible to produce pellets of an appropriate size and the process was not reproducible.     

Role of Surfactant on Drug Release from Tablets

Abstract

The addition of a surfactanat into a tablet formulation appears to be attractive method of improve the drug release rate. The improved release rate is often associated with the effect of surfactant increasing the hydrophilicity of the dosage form thereby promoting drug dissolution. The findings of this investigation showed tha the presence of surfactant infulenced the tablet disintegration rate, producing a finer dispersion of disintergrated particles. It follows that the action of surfactant improving drug dissolution from tablets may be attributed ot the aciton of surfactnat producing fine disintegrated particles with correspondingly larger surface area for drug dissolution. It was also demonstrated that upon tablet disintergration the disinstegrated particles have a tri-moal frequency distribution.     

Role of Surfactant on Drug Release from Tablets

The addition of a surfactanat into a tablet formulation appears to be attractive method of improve the drug release rate. The improved release rate is often associated with the effect of surfactant increasing the hydrophilicity of the dosage form thereby promoting drug dissolution. The findings of this investigation showed tha the presence of surfactant infulenced the tablet disintegration rate, producing a finer dispersion of disintergrated particles. It follows that the action of surfactant improving drug dissolution from tablets may be attributed ot the aciton of surfactnat producing fine disintegrated particles with correspondingly larger surface area for drug dissolution. It was also demonstrated that upon tablet disintergration the disinstegrated particles have a tri-moal frequency distribution.     

Studies on Drug Release Kinetics from Carbomer Matrices

The objective of this study is to gain a mechanistic understanding of drug release kinetics from directly compressed tablets containing Carbopol 934P and 974P resins. Carbopol resins belong to a family of carbomers which are synthetic, high molecular weight, non-linear polymers of acrylic acid, crosslinked with polyalkenyl polyether. They are currently being used as polymeric matrices for controlling drug release in pharmaceutical tablets. This investigation focuses on the influence of the type of drug and the pH of the dissolution media, along with other factors on the drug release kinetics from carbomer matrices. Directly compressed tablets were prepared using a Stokes single station laboratory press and blends of polymers and lactose with drugs like theophylline, norephedrine HCI, and chlorpheniramine maleate. In vitro. drug release studies from the tablets were performed according to USP method II. Drug release rates were obtained by plotting the fraction released versus time and data fitted to the equation:     

Studies on Drug Release Kinetics from Carbomer Matrices

The objective of this study is to gain a mechanistic understanding of drug release kinetics from directly compressed tablets containing Carbopol 934P and 974P resins. Carbopol resins belong to a family of carbomers which are synthetic, high molecular weight, non-linear polymers of acrylic acid, crosslinked with polyalkenyl polyether. They are currently being used as polymeric matrices for controlling drug release in pharmaceutical tablets. This investigation focuses on the influence of the type of drug and the pH of the dissolution media, along with other factors on the drug release kinetics from carbomer matrices. Directly compressed tablets were prepared using a Stokes single station laboratory press and blends of polymers and lactose with drugs like theophylline, norephedrine HCI, and chlorpheniramine maleate. In vitro. drug release studies from the tablets were performed according to USP method II. Drug release rates were obtained by plotting the fraction released versus time and data fitted to the equation:     

Chitosan Matrix Tablets: The Influence of Excipients on Drug Release

Abstract

The influence of excipients on drug release from chitosan matrix tablets was investigated, using diltiazem hydrochloride as model drug. Tablets were prepared by direct compression and the effect of different concentrations of the excipients lactose, sodium lauryl sulphate, sodium alginate, carbopol 934, citric acid and hydroxypropylmethyl-cellulose on drug release profiles was studied. Sustained release of the drug was obtained in all cases but the results indicate that both type and amount of excipient used influences drug release rate. The results support the idea that chitosan can be suitable as a basis for sustained release matrix tablets, and that drug release rate can be influenced by the addition of excipients. It is possible to make use of the interaction between chitosan and excipients in the formulation to provide further prolongation of release.     

Chitosan Matrix Tablets: The Influence of Excipients on Drug Release

The influence of excipients on drug release from chitosan matrix tablets was investigated, using diltiazem hydrochloride as model drug. Tablets were prepared by direct compression and the effect of different concentrations of the excipients lactose, sodium lauryl sulphate, sodium alginate, carbopol 934, citric acid and hydroxypropylmethyl-cellulose on drug release profiles was studied. Sustained release of the drug was obtained in all cases but the results indicate that both type and amount of excipient used influences drug release rate. The results support the idea that chitosan can be suitable as a basis for sustained release matrix tablets, and that drug release rate can be influenced by the addition of excipients. It is possible to make use of the interaction between chitosan and excipients in the formulation to provide further prolongation of release.     

Simultaneous In Vitro Release of Levodopa and Carbidopa from Biocompatible Core-in-Cup Implants

Most implantable drug delivery systems do not release drug at a zero-order rate of release due to their geometry of a decreasing releasing surface. Microcapsules which can release drug at a zero-order rate are very difficult to produce and are prone to dose dumping. The purpose of this study was to test the in vitro release of levodopa and carbidopa from a new core-in-cup bioerodible implantable tablet. Core-in-cup implantable tablets with cups of Resomer® 207, and cores of Resomer RG 746 and Resomer RG 858 were tested. The core-in-cup implantable tablets were tested as to whether they released levodopa or carbidopa at a zeroorder rate. Their rate and extent of erosion in normal saline were also examined. The results indicate that levodopa and carbidopa were released at a zero-order rate in vitro for up to 100 days depending on the inherent viscosity of the polymer used in the core of the implant. It was also found that the rate and extent of erosion of the cup portion of the core-in-cup implantable tablet did not adversely affect the zero-order release of the drugs.     

Effect of Formulation Components on Drug Release from Multiparticulates

The effect of excipients on the release of drug from multiparticulates or pellets coated and uncoated prepared by the extrusion/spheronization and centrifugal processes is reviewed in this paper. A processing viewpoint has been taken because of the relationship between a rugged scaleable process and reliable excipients. Only aqueous coating dispersions have been reviewed because of their increasing usage due to environmental and cost reduction programs.     

Effects of Silicium Dioxide on Drug Release from Suppositories

Abstract

Silica gel is frequently introduced into lipophilic excipients for suppositories as a viscosity agent, to prevent drug sedimentation in the melted mass, and to decrease release rate. The effect of silica gel (Aerosil 200) concentration on the availability of some drugs frequently used in suppositories in different unitary doses was studied. When silica gel concentration in the excipient was increased, a decrease in aminophylline and aminophenazone release rate was observed. Paracetamol in small unitary doses has shown a tendency to increase release rate at higher silica gel concentrations. This behavior was even more evident in suppositories containing promethazine hydrochloride, while for those containing benzydamine hydrochloride the increase in release rate with increasing silica gel concentration was evident for all drug doses. However, the behavior was a consequence of the trend of suppository viscosity during drug release. As a consequence of both the drug and silica gel being discharged, the viscosity progressively decreased with an increased silica gel concentration. The effect on drug availability was conditioned by silica gel concentration, as well as the type and dose of the drug, which could act on the shape of the suppository inner structure that is responsible for viscosity and mobility of drug particles.     

Effects of Silicium Dioxide on Drug Release from Suppositories

Silica gel is frequently introduced into lipophilic excipients for suppositories as a viscosity agent, to prevent drug sedimentation in the melted mass, and to decrease release rate. The effect of silica gel (Aerosil 200) concentration on the availability of some drugs frequently used in suppositories in different unitary doses was studied. When silica gel concentration in the excipient was increased, a decrease in aminophylline and aminophenazone release rate was observed. Paracetamol in small unitary doses has shown a tendency to increase release rate at higher silica gel concentrations. This behavior was even more evident in suppositories containing promethazine hydrochloride, while for those containing benzydamine hydrochloride the increase in release rate with increasing silica gel concentration was evident for all drug doses. However, the behavior was a consequence of the trend of suppository viscosity during drug release. As a consequence of both the drug and silica gel being discharged, the viscosity progressively decreased with an increased silica gel concentration. The effect on drug availability was conditioned by silica gel concentration, as well as the type and dose of the drug, which could act on the shape of the suppository inner structure that is responsible for viscosity and mobility of drug particles.     

Effect of Formulation Components on Drug Release from Multiparticulates

Abstract

The effect of excipients on the release of drug from multiparticulates or pellets coated and uncoated prepared by the extrusion/spheronization and centrifugal processes is reviewed in this paper. A processing viewpoint has been taken because of the relationship between a rugged scaleable process and reliable excipients. Only aqueous coating dispersions have been reviewed because of their increasing usage due to environmental and cost reduction programs.     

Some Factors Affecting the Release of Drug from Membrane Coated Slow Release Tablets

Tablets containing sodium salicylate were prepared by direct compression and coated with ethylcellulose and polyethylene glycol 3350. The effect of drug loading, direct compression carrier type, polymer ratio in the coating solution, pH of the dissolution medium, and agitation speed on the drug release were investigated using the USP XXI paddle method. It was observed that direct compression carriers, ratio of ethyl cellulose to polyethylene glycol, the amount of drug present in the tablet, and agitation speed used did not have any influence on the drug release from coated tablets, while the pH of the dissolution medium (gastric vs. intestinal fluids) was found to affect the drug release.